The effects of Cernitin® on inflammatory parameters and benign prostatic hyperplasia: An in vitro study

@article{Dizeyi2019TheEO,
  title={The effects of Cernitin® on inflammatory parameters and benign prostatic hyperplasia: An in vitro study},
  author={N. Dizeyi and I. Mattisson and Lena Ramnemark and M. Grabe and Per‐Anders Abrahamsson},
  journal={Phytotherapy Research},
  year={2019},
  volume={33},
  pages={2457 - 2464}
}
  • N. Dizeyi, I. Mattisson, +2 authors Per‐Anders Abrahamsson
  • Published 2019
  • Chemistry, Medicine
  • Phytotherapy Research
  • The pollen extract Cernitin® is widely used for treatment of benign prostatic hyperplasia (BPH) and non‐bacterial chronin prostatitis. However, little is known about the underlying molecular mechanisms to explain the clinical effects of Cernitin®. In this study, we sought to investigate the cellular mechanisms by which Cernitin® induces its effects on human prostatic cell lines BPH‐1 and WPMY‐1 and primary human peripheral blood mononuclear cells (hPBMCs) in vitro. We examined the effects of… CONTINUE READING

    References

    SHOWING 1-10 OF 29 REFERENCES
    [Effects of cernitin pollen-extract (Cernilton) on inflammatory cytokines in sex-hormone-induced nonbacterial prostatitis rats].
    • 19
    • Highly Influential
    • PDF
    [Inhibition of arachidonic acid cascade by extract of rye pollen].
    • 20